ホーム>>GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt)

GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt) (Synonyms: Glucagon-like Peptide-1 (7-37) (human, bovine, guinea pig, mouse, rat))

カタログ番号GC43763

グルカゴン様ペプチド-1(GLP-1)(7-37)は内因性のインクレチンホルモンであり、膵臓と腸で前駆体グルカゴンの切断によって生成されるGLP-1(1-37)の切り詰められた形式です。

Products are for research use only. Not for human use. We do not sell to patients.

GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
500μg
$255.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glucagon-like peptide-1 (GLP-1) (7-37) is an endogenous incretin hormone and truncated form of GLP-1 (1-37) that is produced via cleavage of preproglucagon in the pancreas and intestine. It binds to βTC-1 and RIN 1027-B2 cells (Kds = 3.3 and 3.5 nM, respectively) and enhances insulin secretion in βTC-1 cells in a concentration- and glucose-dependent manner. Ex vivo, GLP-1 (7-37) stimulates insulin release from perfused rat pancreas. GLP-1 (7-37) increases plasma insulin concentrations by greater than 50% as compared to vehicle control in response to hyperglycemia in rats when administered at a dose of 15 pmol/min/kg for five days.

レビュー

Review for GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.